AlloCure's kidney disease treatment advancesMass High TechBy Michelle Lang The US Food and Drug Administration has granted fast track designation to Burlington biotech startup AlloCure Inc. for AC607, its potential treatment of acute kidney injury …
Heart Failure, Diabetes Might Be Linked by Protein – U.S. News & World Report
Heart Failure, Diabetes Might Be Linked by ProteinU.S. News & World ReportThe team at Chiba University in Japan found that the stress of heart failure activates a protein called p53, resulting in inflammation in fat tissue, systemic insulin resistance …
Pair cycling to promote blood donation – Otago Daily Times
Otago Daily TimesPair cycling to promote blood donationOtago Daily TimesThey are touring the world promoting blood donation. Photo by Peter McIntosh. Frenchman Julien Leblay (30) travels the world encouraging people to give blood, but most countries…
Boston Scientific Stent, With New Drug Coating, Wins FDA Approval – Xconomy
Boston Scientific Stent, With New Drug Coating, Wins FDA ApprovalXconomyThe FDA cleared for sale the Promus stent that secretes everolimus, a drug designed to reduce scar tissue around the device and reduce blockages. Natick, MA-based Boston Scientific…
Heart Failure – Cardiac Resynchronization Therapy Is Effective – Medical News Today
Heart Failure – Cardiac Resynchronization Therapy Is EffectiveMedical News TodayHeart failure continues to be the most prevalent reason for acute hospital admission, although it is stubbornly resistant to treatment. Mortality and morbidity rates remain…
CHKM, ALXN, RDDY, HOLI, FSIN, EXAR are Stocks to Watch on Jan-5 Morning – Beacon Equity Research
CHKM, ALXN, RDDY, HOLI, FSIN, EXAR are Stocks to Watch on Jan-5 MorningBeacon Equity ResearchTheir market cap is 13.18B . Alexion Pharmaceuticals, Inc is engaged in the discovery, development and delivery of biologic therapeutic products and life-threa…
EyeGate Pharma Initiates Phase III Study of EGP-437 in Patients With Anterior … – MarketWatch (press release)
EyeGate Pharma Initiates Phase III Study of EGP-437 in Patients With Anterior …MarketWatch (press release)The randomized double-masked positive-controlled non-inferiority study will enroll up to 200 subjects at more than 20 US sites in order to asses…
Jeffrey S. Burkholder – North Fort Myers Neighbor
Jeffrey S. BurkholderNorth Fort Myers NeighborA resident of Cape Coral and North Fort Myers since 1988, Jeffrey graduated from Fort Myers High School in 1989 the same year that he underwent transplant surgery for a new kidney. He was very active in Spe…
Henry Studio to Host Doug Lack Fundraiser – Patch.com
Henry Studio to Host Doug Lack FundraiserPatch.comOwners expect to donate up to $1000 to the art teacher who must soon undergo kidney transplant surgery. By Justin Saglio Art teacher Doug Lack stands next to several creations by some of students at Hol…
Rigel Announces Initiation of Clinical Trials in Two Immunology Programs – MarketWatch (press release)
Rigel Announces Initiation of Clinical Trials in Two Immunology ProgramsMarketWatch (press release)The company is evaluating R548, an oral JAK3 inhibitor, as a potential therapeutic for transplant rejection and other systemic immune disorders. The seco…